EUVIMEDEUVIMED entdecken
Crossref

Sonrotoclax (BGB-11417) synergistically amplifies the radiotherapy-elicited anti-tumor immune response

Mengmeng Ma, Zengfu Zhang, Chen Tian, Xu Liu, Meng Wu, Jinming Yu, Jupeng Yuan, Dawei Chen

Cancer Letters · 2025-08 · 625 · 217759

DOI: 10.1016/j.canlet.2025.217759 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Letters, 2025-08. Verfasst von Mengmeng Ma und 7 weiteren Autor:innen. Beteiligte Einrichtung: Shandong Provincial Key Laboratory of Precision Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Acad…. Hauptthemen laut MEDLINE: Proto-Oncogene Proteins c-bcl-2, Neoplasms. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 41 Literaturangaben. Gefördert von: Natural Science Foundation of Shandong Province, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Proto-Oncogene Proteins c-bcl-2NeoplasmsHumansAnimalsMiceCell Line, TumorTumor MicroenvironmentTumor-Associated MacrophagesCD8-Positive T-LymphocytesXenograft Model Antitumor AssaysFerroptosisApoptosisFemaleSignal Transduction

Stichwörter der Autor:innen

BCL-2 inhibitorImmunogenic ferroptosisMacrophageRadiotherapySonrotoclaxcGAS-STING

Substanzen

Proto-Oncogene Proteins c-bcl-2BCL2 protein, human

Autor:innen und Institutionen

  • Shandong Provincial Key Laboratory of Precision Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, Shandong, China.
  • Department of Radiation Oncology, Shandong University Cancer Center, Jinan, Shandong, China.
  • Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
  • Shandong Provincial Key Laboratory of Precision Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, Shandong, China. Electronic address: s…
  • Shandong Provincial Key Laboratory of Precision Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, Shandong, China. Electronic address: y…
  • Shandong Provincial Key Laboratory of Precision Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, Shandong, China; Department of Radiati…

Förderung

  • Natural Science Foundation of Shandong Province
  • National Natural Science Foundation of China

Zitieren

APA

Ma, M., Zhang, Z., Tian, C., Liu, X., Wu, M., Yu, J., Yuan, J., & Chen, D. (2025). Sonrotoclax (BGB-11417) synergistically amplifies the radiotherapy-elicited anti-tumor immune response. Cancer Letters, 625, 217759. https://doi.org/10.1016/j.canlet.2025.217759

Vancouver

Ma M, Zhang Z, Tian C, Liu X, Wu M, Yu J, et al. Sonrotoclax (BGB-11417) synergistically amplifies the radiotherapy-elicited anti-tumor immune response. Cancer Letters. 2025;625:217759. doi:10.1016/j.canlet.2025.217759

BibTeX
@article{Ma2025,
  author = {Ma, Mengmeng and Zhang, Zengfu and Tian, Chen and Liu, Xu and Wu, Meng and Yu, Jinming and Yuan, Jupeng and Chen, Dawei},
  title = {Sonrotoclax (BGB-11417) synergistically amplifies the radiotherapy-elicited anti-tumor immune response},
  journal = {Cancer Letters},
  year = {2025},
  volume = {625},
  pages = {217759},
  doi = {10.1016/j.canlet.2025.217759}
}
Kostenlos starten →